DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,074 filers reported holding DANAHER CORPORATION in Q4 2022. The put-call ratio across all filers is 1.10 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $656,774 | -3.8% | 2,839 | +3.2% | 0.03% | -10.5% |
| Q3 2023 | $682,771 | +0.9% | 2,752 | -2.4% | 0.04% | +5.6% |
| Q2 2023 | $676,560 | +667.9% | 2,819 | -13.7% | 0.04% | +20.0% |
| Q4 2022 | $88,103 | -88.5% | 3,268 | +8.4% | 0.03% | -40.0% |
| Q3 2022 | $764,000 | 0.0% | 3,015 | 0.0% | 0.05% | 0.0% |
| Q2 2022 | $764,000 | -12.4% | 3,015 | +1.4% | 0.05% | +2.0% |
| Q1 2022 | $872,000 | -19.0% | 2,974 | -9.2% | 0.05% | -16.9% |
| Q4 2021 | $1,077,000 | +16.9% | 3,274 | +8.3% | 0.06% | +3.5% |
| Q3 2021 | $921,000 | +10.2% | 3,024 | -2.9% | 0.06% | +9.6% |
| Q2 2021 | $836,000 | +12.4% | 3,115 | -5.8% | 0.05% | +4.0% |
| Q1 2021 | $744,000 | +1.4% | 3,306 | 0.0% | 0.05% | -3.8% |
| Q4 2020 | $734,000 | +3.1% | 3,306 | -0.1% | 0.05% | -10.3% |
| Q3 2020 | $712,000 | +18.1% | 3,308 | -3.0% | 0.06% | +9.4% |
| Q2 2020 | $603,000 | +22.6% | 3,409 | -4.1% | 0.05% | +10.4% |
| Q1 2020 | $492,000 | -12.1% | 3,556 | -2.6% | 0.05% | +2.1% |
| Q4 2019 | $560,000 | -67.6% | 3,651 | -69.4% | 0.05% | -74.7% |
| Q3 2019 | $1,726,000 | -9.4% | 11,947 | -10.4% | 0.19% | -10.6% |
| Q2 2019 | $1,905,000 | +1.1% | 13,330 | -6.6% | 0.21% | +1.5% |
| Q1 2019 | $1,884,000 | +11.0% | 14,272 | -13.3% | 0.20% | +2.0% |
| Q4 2018 | $1,698,000 | +2.2% | 16,463 | +7.7% | 0.20% | +8.1% |
| Q3 2018 | $1,661,000 | +11.3% | 15,288 | +1.1% | 0.19% | +4.5% |
| Q2 2018 | $1,493,000 | +11.0% | 15,125 | +10.1% | 0.18% | +4.7% |
| Q1 2018 | $1,345,000 | +7.0% | 13,740 | +1.5% | 0.17% | +13.3% |
| Q4 2017 | $1,257,000 | +16.1% | 13,537 | +7.2% | 0.15% | +10.3% |
| Q3 2017 | $1,083,000 | +7.4% | 12,630 | +5.8% | 0.14% | +0.7% |
| Q2 2017 | $1,008,000 | +10.9% | 11,939 | +12.4% | 0.14% | +6.3% |
| Q1 2017 | $909,000 | +13.5% | 10,625 | +3.2% | 0.13% | +17.6% |
| Q4 2016 | $801,000 | +16.3% | 10,295 | +17.1% | 0.11% | +12.5% |
| Q3 2016 | $689,000 | -14.3% | 8,791 | +10.4% | 0.10% | -14.3% |
| Q2 2016 | $804,000 | +12.9% | 7,961 | +6.1% | 0.11% | +9.8% |
| Q1 2016 | $712,000 | +29.7% | 7,506 | +27.0% | 0.10% | +22.9% |
| Q4 2015 | $549,000 | – | 5,912 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CROSBY Co OF NEW HAMPSHIRE LLC | 224,667 | $17,688,000 | 10.64% |
| RobecoSam USA, Inc. | 102,422 | $8,063,000 | 8.78% |
| CORTLAND ASSOCIATES INC/MO | 466,424 | $36,722,000 | 7.33% |
| Red Rocks Capital LLC | 324,527 | $25,550,000 | 7.05% |
| Five Oceans Asset Management LTD | 327,112 | $25,754,000 | 5.88% |
| Robeco Schweiz AG | 739,101 | $58,529,000 | 4.77% |
| TRAN CAPITAL MANAGEMENT, L.P. | 3,428,966 | $269,962,000 | 4.72% |
| ASHMORE WEALTH MANAGEMENT LLC | 3,000,000 | $236,192,000 | 4.56% |
| CADINHA & CO LLC | 324,429 | $25,542,000 | 4.31% |
| BI Asset Management Fondsmaeglerselskab A/S | 503,250 | $39,621,000 | 4.31% |